article thumbnail

Addressing Specialty Pharmacy Adherence Challenges Head On

Omnicell

To date, Omnicell has a 92% PA approval rate for all indications of XIFAXAN and the average turnaround time for medication delivery to patients is less than two days. Medication Adherence: The Elephant in the Room, U.S. Pharmacist, January 2019 IQVIA Institute for Human Data Science 2022

article thumbnail

Injecting Innovation: The Rising Trend of Autoinjectors in Modern Medicine

Roots Analysis

The continuous evolution of autoinjectors reflects a significant shift towards empowering patients to take control of their treatment, ensuring timely and accurate medication delivery for better health management. It is worth mentioning that patent filing has increased rapidly at a CAGR of 29%, between 2019 and 2023.

Dosage 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Pharma’s post-pandemic launch performance problem: what’s the prognosis?

pharmaphorum

Launches, therefore, were happening. But were they fulfilling their commercial potential? On average, across the eight countries that provide over 90% of the first five years’ commercial potential for launch medicines, the answer is no.

article thumbnail

Dr. Harmony Garges, CMO at ViiV Healthcare, Shares Insights on Positive Findings from the SOLAR Study of Cabenuva

PharmaShots

Harmony Garges is the Chief Medical Officer at ViiV Healthcare. She joined ViiV Healthcare in 2016 and held several roles in Global Medical Affairs before assuming her current role as Chief Medical Officer at the company in 2019.